Rotavirus Vaccine

 

Reviewed by Clinical Practice Committee
June 2014
Clinical Guidelines Back Newborn Services Home Page
Dosage Interval Contraindications Dosage Administration References

 

Rota Teq®

Merck, Sharpe and Dohme (New Zealand) Ltd

Live attenuated oral vaccine

Rota Teq® induces antibodies against five serotypes of rotavirus, G1-4 and P. Exact mechanism unknown2.

Indications

Dosage interval

Contraindications

Supplied As

Dosage

Interval

Administration

Full Administration Instructions

Compatible With

Interactions

Precautions

Stability

Storage

Adverse Reactions

Metabolism

Comments

References

1 www.nzfc.org.nz
2  http://www.medsafe.govt.nz/profs/datasheet/r/TotaTeqsusp.pdf
3 www.immune.org.nz Rotavirus and Rota Teq® vaccine; Factsheet for vaccinators and health professionals
4 http://www.health.govt.nz/publication/immunisation-handbook-2014